Onderneming Sirona Biochem Corp Toronto S.E.
Aandelen
SBM
CA82967M1005
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Cosmetic and Pharmaceutical Active Ingredients
100,0
%
| 1 | 100,0 % | 0 | 100,0 % | -94,82% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Howard Verrico
CEO | Chief Executive Officer | - | 19-10-06 |
Director of Finance/CFO | - | 29-04-09 | |
Chief Tech/Sci/R&D Officer | - | 31-03-11 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Howard Verrico
CEO | Chief Executive Officer | - | 19-10-06 |
Alex Marazzi
BRD | Director/Board Member | - | 19-10-06 |
Director of Finance/CFO | - | 29-04-09 | |
Chief Tech/Sci/R&D Officer | - | 31-03-11 | |
Jason Tian
BRD | Director/Board Member | - | 07-06-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 256 454 505 | 229 289 516 ( 89,41 %) | 0 | 89,41 % |
Bedrijfsgegevens
Sirona Biochem Corp.
595 Burrard Street Suite 1600
V7X 1L4, Vancouver
+604-641-4466
http://www.sironabiochem.comSector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+51,85% | 57,87 mld. | |
+41,42% | 40,25 mld. | |
-5,25% | 39,94 mld. | |
-5,16% | 28,54 mld. | |
+12,79% | 26,4 mld. | |
-20,18% | 19,33 mld. | |
+30,88% | 12,4 mld. | |
+0,61% | 12,23 mld. | |
+25,06% | 12,2 mld. |